Philippe Ravassard
Inventor
Stats
- 3 US patents issued
- 8 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 8 US Applications Filed
- 5 Total Citation Count
- Jan 12, 2023 Most Recent Filing
- Oct 14, 1998 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| UNIVERSITE PARIS VII | 1
| 2002
|
| AVENTIS PHARMA S.A. | 1
| 1998
|
| CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE | 1
1 2 | 2002
2008 2012 |
| INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) | 1
2 | 2008
2012 |
| SARL ENDOCELLS | 1
| 2008
|
| UNIVERCELL BIOSOLUTIONS | 2
| 2012
|
| CENTELION | 1
| 2000
|
Inventor Addresses
| Address | Duration |
|---|---|
| Paris, FR | Aug 13, 02 - Oct 05, 23 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01K: | ANIMAL HUSBANDRY; CARE OF BIRDS, FISHES, INSECTS; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 3 |
| A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 2023/0313,161 | 2023 | DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF | 0 |
| 2019/0185,832 | 2019 | DIET CONTROLLED EXPRESSION OF A NUCLEIC ACID ENCODING CAS9 NUCLEASE AND USES THEREOF | 0 |
| 2019/0136,196 | 2019 | HUMAN PANCREATIC BETA CELL LINES FOR DIAGNOSTIC OF DIABETES | 0 |
| 10167450 | 2019 | Human pancreatic beta cell lines for diagnostic of diabetes | 0 |
| 9493743 | 2016 | Production of a human beta cell line from an early post natal pancreas | 0 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.